SRPT
Sarepta Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.50
−2.13%Leverage
- Debt / equity
- 0.68x
- Net debt / equity
- 0.31x
- Debt / assets
- 0.33x
- Debt / EBITDA
- -71.71x
- Net debt / EBITDA
- -32.55x
Liquidity & coverage
- Current ratio
- 4.42x
- Quick ratio
- 2.62x
- Cash ratio
- 1.57x
- Interest coverage
- -2.45x
- EBITDA / interest
- -0.25x
- Working capital
- $1.7B
Cash & dividend
- FCF / debt
- -0.13x
- Cash flow / debt
- -0.09x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026